Milagro has acquired Mycratine, a migraine remedy product, and will rebrand packaging, marketing, and distribution as Migraine Solutions. Mycratine is already a powerful consumer packaged good (CPG) product available in US stores nationwide. Migraine Solutions will also add CBD and other cannabinoids in countries where legislation has passed.

Mycratine Migraine Relief is a patented, fast-acting homeopathic complex liquid shot formula that activates the neurological receptors in the brain to bring it back into balance.

The patented process isolates the SNRA molecule which separates and removes virtually all taste, smell and oils from the nicotine molecule and bonds it with water.

SNRA produces its biological effects by activating specific receptors in the brain called acetylcholine receptors. SNRA modulates neurotransmitter pools in the brain, in particular, serotonin.

Delivered at small homeopathic dosages, the SNRA molecule powering Migraine Solutions results in a fast-acting, long-lasting migraine relief formula.